reported that 55% of subjects with new-onset T1D and detectable stimulated C-peptide level of >300 pmol/L had low insulin sensitivity (i.e., high IR) and thus were not in remission when assessed by insulin-dose adjusted A1c (74). Here, INS is linked to type 1 diabetes mellitus.